NCT06588179View on ClinicalTrials.gov

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
NMIBC
Interventions
DRUG

SHR-1501+SHR-2005

SHR-1501, instillation；SHR-2005, instillation

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT06588179 - SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt | Biotech Hunter | Biotech Hunter